Key points are not available for this paper at this time.
Design
Editorial
Answers are grounded in this paper and cite their sources.
Discusses the role of pharmacogenetics in tailoring treatments to individual variability, moving beyond the population averages of randomized controlled trials.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Woodcock et al. (2009) reported an editorial.
Synapse has enriched 10 related papers. Consider them for comparative context: